发明名称 Modulators of ATP-binding cassette transporters
摘要 Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
申请公布号 US8952050(B2) 申请公布日期 2015.02.10
申请号 US201314036286 申请日期 2013.09.25
申请人 Vertex Pharmaceuticals Incorporated 发明人 Ruah Sara Sabina Hadida;Grootenhuis Peter Diederik Jan;Van Goor Fredrick F.;Zhou Jinglan;Bear Brian Richard;Miller Mark Thomas;McCartney Jason;Numa Mehdi;Yang Xiaoqing
分类号 C07D405/12;A61K31/36;C07D209/08;C07D405/14;C07D471/04;C07D233/64;C07D403/12 主分类号 C07D405/12
代理机构 Honigman Miller Schwartz and Cohn LLP 代理人 Honigman Miller Schwartz and Cohn LLP ;Berven Heidi M.;O'Brien Jonathan P.
主权项 1. A method of activating Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) activity comprising the step of contacting the CFTR with a compound of formula I: or a pharmaceutically acceptable salt thereof; wherein, independently for each occurrence: R1 and R2 are —ZAR4, wherein each ZA is independently a bond or an optionally substituted branched or straight C1-6 aliphatic chain wherein up to two carbon units of ZA are optionally and independently replaced by —CO—, —CS—, —CONRA—, —CONRANRA—, —CO2—, —OCO—, —NRACO2—, —O—, —NRACONRA—, —OCONRA—, —NRANRA—, —NRACO—, —S—, —SO—, —SO2—, —NRA—, —SO2NRA—, —NRASO2—, or —NRASO2NRA—; or any two adjacent R2 groups together with the atoms to which they are attached form an optionally substituted carbocycle or optionally substituted heterocycle; R4 is independently RA, halo, —OH, —NH2, —NO2, —CN, or —OCF3; RA is independently hydrogen, an optionally substituted aliphatic, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, an optionally substituted aryl, or an optionally substituted heteroaryl; ring A is an optionally substituted 3-7 membered monocyclic ring having 0-3 heteroatoms selected from N, O, and S; n is and integer from 1 to 3 inclusive; ring B is wherein:p is 2 or 3; andR3 is C1-C6 aliphatic or halo, and;R′3 is —ZCR6, whereZC is an optionally substituted branched or straight C1-6 aliphatic chain wherein up to two carbon units of ZC are optionally and independently replaced by —CO—, —CS—, —CONRC—, —CONRCNRC—, —CO2—, —OCO—, —NRCCO2—, —O—, —NRCCONRC—, —OCONRC—, —NRCNRC—, NRCCO—, —S—, —SO—, —SO2—, —NRC, —SO2NRC—, —NRCSO2—, or —NRCSO2NRC—;R6 is RC, halo, —OH, —NH2, —NO2, —CN, or —OCF3;RC is hydrogen, an optionally substituted aliphatic, an optionally substituted cycloaliphatic, an optionally substituted heterocycloaliphatic, or an optionally substituted heteroaryl;and wherein when one of the 2 or 3 R3 is adjacent to R′3 and the adjacent R3 is C1-C6 aliphatic, then R′3 and the adjacent R3, together with the atoms to which they are attached, form an optionally substituted heterocycle.
地址 Boston MA US